Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Evette Mitkov

Intellia Therapeutics Shares Are Ripping Higher: Here's Why

Intellia Therapeutics Inc

Intellia Therapeutics Inc (NASDAQ:NTLA) shares are soaring on Thursday after the company completed enrollment in its crucial Phase 3 HAELO trial and laid out its key development milestones.

What Happened:  Intellia announced that it concluded patient enrollment in the global Phase 3 HAELO study of lonvoguran ziclumeran (lonvo-z) within nine months of dosing the first subject.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.